Skip to main content
OpenTrials

Clinical trial condition

Hodgkin's Lymphoma

Explore clinical trials studying Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

66 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Hodgkin's Lymphoma trial results

Completed

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

NCT00896454

Conditions
Blood Protein Disorders, Breast Cancer, Breast Diseases, +77 more
Locations
  • Research Site Encinitas, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Salisbury, Maryland, United States
  • Research Site Dearborn, Michigan, United States
View all 24 locations
View Trial Details
Completed

A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma

NCT01877005

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
Locations
  • UCL Louvain St Luc Brussels, Belgium
  • Université Catholique de Louvain Mont Godinne Yvoir, Belgium
  • Chu Cote de Nacre Caen, France
  • Hopital Henri Mondor Créteil, France
View Trial Details
Completed

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients

NCT00784537

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
Locations
  • Centro di riferimento Oncologico Oncologia Medica A Aviano, Italy
  • Università Policlinico di Bari - Divisione di Medicina A Bari, Italy
  • Policlinco Sant'Orsola Isituto di Ematologia ed oncologia Medica Bologna, Italy
  • Sezione di Ematologia Spedali Civili Brescia, Italy
View all 27 locations
View Trial Details
Completed

Tandem Auto-Allo Transplant for Lymphoma

NCT01181271

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse, Large B-Cell, Lymphoma, +27 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)

NCT01034163

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Georgia Health Sciences University Medical College of Georgia Augusta, Georgia, United States
  • Northwestern University Oncology Chicago, Illinois, United States
View all 35 locations
View Trial Details

Related conditions